secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcus Biosciences, Inc. (RCUS)
CIK:        0001724521
Form:       8-K
Filed at:   2025-06-12T23:59:59+00:00
Accession:  0001724521-25-000078
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.07, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcus annual meeting elects directors, ratifies E&Y, approves say-on-pay; board revises director comp
--------------------------------------------------------------------------------

- All four Class I director nominees elected with >86M votes each (broker non-votes ~8.6M).
- Ernst & Young ratified as auditor for FY2025 with 96.8M votes for (96.3% of votes cast).
- Advisory 'say-on-pay' approved with 84.8M for (93.9% of votes cast excluding abstentions).
- Board revised Non-Employee Director Compensation Program: $50k cash retainer, $750k initial equity, $400k annual equity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1724521/000172452125000078/0001724521-25-000078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1724521/000172452125000078/rcus-20250610.htm
  HTML page:      https://secwatch.observer/filing/0001724521-25-000078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer